{"id":3142,"company":{"country":"US","currency":"USD","exchange":"NEW YORK STOCK EXCHANGE, INC.","ipo":"2000-03-27","marketCap":55638.3,"name":"Edwards Lifesciences Corp","phone":"19492502500","outstanding":601.3,"symbol":"EW","website":"https://www.edwards.com","industry":"Health Care"},"price":93.5525,"year":2024,"month":3,"day":20,"weekday":"Wednesday","title":"The Impact of Currency Fluctuations on Edwards Lifesciences Corp","date":"2024-03-20","url":"/posts/2024/03/20/EW","content":[{"section":"Introduction","text":"Edwards Lifesciences Corp is a global medical technology company that operates in multiple countries. As a multinational corporation, it is exposed to currency fluctuations, which can have both positive and negative impacts on its financial performance."},{"section":"Case Study 1: Strong Dollar","text":"In 2015, Edwards Lifesciences Corp faced significant challenges due to a strong US dollar. The company derived a substantial portion of its revenue from international markets, particularly in Europe. As the US dollar strengthened against the Euro, the revenue earned in Euros converted into fewer dollars, resulting in a decline in reported revenues. This currency headwind had a negative impact on the company's financial results, leading to a decrease in stock prices."},{"section":"Case Study 2: Weak Currency","text":"Conversely, in 2020, Edwards Lifesciences Corp benefited from a weak Brazilian Real. Brazil is one of the company's important markets, and a devaluation of the Real against the US dollar increased the translated value of Brazilian revenues. This currency tailwind played a significant role in boosting the company's reported revenues and profitability, leading to a positive impact on the stock price."},{"section":"Balanced Assessment: Currency Risk","text":"Currency fluctuations present both opportunities and risks for multinational companies like Edwards Lifesciences Corp. On one hand, a strong domestic currency can hinder competitiveness and erode profitability when converting foreign earnings. On the other hand, a weaker currency in foreign markets can enhance competitiveness and improve profitability when converting earnings back to the home currency."},{"section":"Benefits of Currency Hedging","text":"To mitigate the impact of currency fluctuations, multinational companies often engage in currency hedging strategies. These strategies involve using financial instruments, such as forward contracts, options, or currency swaps, to protect against adverse currency movements. By hedging their currency exposure, companies like Edwards Lifesciences Corp aim to stabilize their financial results and reduce the unpredictability of foreign exchange movements."},{"section":"Conclusion","text":"Currency fluctuations have a significant impact on Edwards Lifesciences Corp's multinational stock. Real-world case studies demonstrate the effects of currency risk, highlighting the potential benefits and drawbacks. A balanced assessment recognizes that currency fluctuations can create both positive and negative outcomes for the company's financial performance. Employing effective currency hedging strategies can help mitigate the risks associated with currency volatility and provide a level of stability in the company's stock performance."}],"tags":["LongSignals","Long","Health Care"],"news":[{"category":"company","date":1710872640,"headline":"Edwards Lifesciences Stock Earns Relative Strength Rating Upgrade; Hits Key Benchmark","id":126580208,"image":"","symbol":"EW","publisher":"Yahoo","summary":"IBD's proprietary RS Rating identifies market leadership by using a 1 (worst) to 99 (best) score that shows how a stock's price performance over the last 52 weeks matches up against the rest of the market.  Decades of market research reveals that the best-performing stocks often have an RS Rating north of 80 as they begin their biggest climbs.  Is Edward Lifesciences Stock A Buy?","url":"https://finance.yahoo.com/m/f52fe496-dbf5-30cd-9134-920baf01723e/edwards-lifesciences-stock.html"},{"category":"company","date":1710869880,"headline":"Edwards Lifesciences (EW) Up 21.8% YTD: What's Driving It?","id":126579761,"image":"https://media.zenfs.com/en/zacks.com/529a2bf6a4c772f942409efa3808349b","symbol":"EW","publisher":"Yahoo","summary":"Investors are optimistic about Edwards Lifescience's (EW) substantial growth across each of its four product groups.","url":"https://finance.yahoo.com/news/edwards-lifesciences-ew-21-8-173800746.html"},{"category":"company","date":1710846043,"headline":"Edwards Lifesciences Corporation's (NYSE:EW) Intrinsic Value Is Potentially 17% Below Its Share Price","id":126571873,"image":"https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09","symbol":"EW","publisher":"Yahoo","summary":"Key Insights Using the 2 Stage Free Cash Flow to Equity, Edwards Lifesciences fair value estimate is US$76.80 Edwards...","url":"https://finance.yahoo.com/news/edwards-lifesciences-corporations-nyse-ew-110043682.html"},{"category":"company","date":1710831900,"headline":"PECA Labs Receives Expanded CE Mark for exGraft Family of Vascular Grafts, Allowing for Expandability Designed to Match Growth or Help Avoid Restenosis","id":126577584,"image":"","symbol":"EW","publisher":"Business Wire","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=1tzdvr6b89"},{"category":"company","date":1710744660,"headline":"Analysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS), Edwards Lifesciences (EW) and Aveanna Healthcare Holdings (AVAH)","id":126555827,"image":"","symbol":"EW","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3403126139"},{"category":"company","date":1710744060,"headline":"Edwards Lifesciences price target raised by $7 at Oppenheimer, here's why","id":126559166,"image":"","symbol":"EW","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3403116523"},{"category":"company","date":1710516644,"headline":"IQVIA (IQV) Up 5.3% Since Last Earnings Report: Can It Continue?","id":126520709,"image":"","symbol":"EW","publisher":"Yahoo","summary":"IQVIA (IQV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.","url":"https://finance.yahoo.com/news/iqvia-iqv-5-3-since-153044112.html"},{"category":"company","date":1710514200,"headline":"Edwards Lifesciences (EW) Hits 52-Week High: What's Driving It?","id":126520710,"image":"https://media.zenfs.com/en/zacks.com/41b7bdd28f63138df08f17b665d3589a","symbol":"EW","publisher":"Yahoo","summary":"Edwards Lifesciences (EW) outperforms the industry, owing to a robust 2023 fourth-quarter performance, as well as the strong potential in the TMTT division.","url":"https://finance.yahoo.com/news/edwards-lifesciences-ew-hits-52-145000383.html"},{"category":"company","date":1710424080,"headline":"Buy 5 Medical Devices Stocks for a Stable Portfolio in 2024","id":126499214,"image":"","symbol":"EW","publisher":"Yahoo","summary":"We have narrowed our search to five Medical Instruments stocks with strong potential for 2024. These are: AORT, TMDX, DXCM, SWAV, EW.","url":"https://finance.yahoo.com/news/buy-5-medical-devices-stocks-134800061.html"},{"category":"company","date":1710421320,"headline":"Zacks Investment Ideas feature highlights: Tenet Healthcare and HCA Healthcare","id":126497588,"image":"https://media.zenfs.com/en/zacks.com/9f7296fade0c729cbae8baf4df367222","symbol":"EW","publisher":"Yahoo","summary":"Tenet Healthcare and HCA Healthcare are part of the Zacks Investment Ideas article.","url":"https://finance.yahoo.com/news/zacks-investment-ideas-feature-highlights-130200229.html"},{"category":"company","date":1710412620,"headline":"Here's How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 15 Years","id":126510290,"image":"","symbol":"EW","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3397781467"},{"category":"company","date":1710406500,"headline":"Early notable gainers among liquid option names on March 14th","id":126505457,"image":"","symbol":"EW","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3397638988"},{"category":"company","date":1710394860,"headline":"Analystsâ€™ Top Healthcare Picks: Edwards Lifesciences (EW), Arrowhead Pharmaceuticals (ARWR)","id":126502893,"image":"","symbol":"EW","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3397412654"},{"category":"company","date":1710347880,"headline":"Medical Devices ETF Hits 52-Week High: Stocks to Watch","id":126480752,"image":"","symbol":"EW","publisher":"Yahoo","summary":"Historically viewed as a defensive area, health care also boasts many growth aspects and benefits from advances in technology.","url":"https://finance.yahoo.com/news/medical-devices-etf-hits-52-163800119.html"},{"category":"company","date":1710345420,"headline":"Edwards Lifesciences' (EW) SAPIEN TAVR Study Outcome Favorable","id":126480669,"image":"https://media.zenfs.com/en/zacks.com/529a2bf6a4c772f942409efa3808349b","symbol":"EW","publisher":"Yahoo","summary":"Edwards Lifesciences' (EW) recent study provides insights into the actual performance of small Edwards valves and reaffirms the excellent outcomes for patients receiving SAPIEN TAVR.","url":"https://finance.yahoo.com/news/edwards-lifesciences-ew-sapien-tavr-155700839.html"},{"category":"company","date":1710299760,"headline":"Buy Rating on Edwards Lifesciences Amid Expanding TAVR Market and Positive SMART Trial Outlook","id":126476377,"image":"","symbol":"EW","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3395421859"},{"category":"company","date":1710180000,"headline":"Large, Real-world Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVR","id":126445923,"image":"","symbol":"EW","publisher":"Yahoo","summary":"WASHINGTON, March 11, 2024--Edwards Lifesciences (NYSE: EW) announced today at Cardiovascular Research Technologies (CRT) 2024 the compelling results from two large, real-world studies based on TVT Registry data that demonstrated continued excellent outcomes for patients treated with the Edwards SAPIEN valve platform.","url":"https://finance.yahoo.com/news/large-real-world-studies-demonstrate-180000533.html"},{"category":"company","date":1710160205,"headline":"Here's How Much a $1000 Investment in Edwards Lifesciences Made 10 Years Ago Would Be Worth Today","id":126445924,"image":"","symbol":"EW","publisher":"Yahoo","summary":"Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.","url":"https://finance.yahoo.com/news/heres-much-1000-investment-edwards-123005944.html"},{"category":"company","date":1710151320,"headline":"Edwards Lifesciences Corp (EW)'s Winning Formula: Financial Metrics and Competitive Strengths","id":126441070,"image":"","symbol":"EW","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3392213763"},{"category":"company","date":1709892420,"headline":"Interesting EW Put And Call Options For April 19th","id":126400641,"image":"","symbol":"EW","publisher":"Stock Options Channel","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3388616810"},{"category":"company","date":1709878800,"headline":"EW Crosses Above Average Analyst Target","id":126400643,"image":"","symbol":"EW","publisher":"ETF Channel","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3388356591"},{"category":"company","date":1709852810,"headline":"B of A Securities Upgrades Edwards Lifesciences (EW)","id":126388346,"image":"","symbol":"EW","publisher":"Fintel","summary":"","url":"https://fintel.io/news/b-of-a-securities-upgrades-edwards-lifesciences-ew-772"},{"category":"company","date":1709829067,"headline":"Edwards Lifesciences (EW) Up 2% Since Last Earnings Report: Can It Continue?","id":126381609,"image":"https://media.zenfs.com/en/zacks.com/ac90b3d74679f6d01a122aa033d8a9a4","symbol":"EW","publisher":"Yahoo","summary":"Edwards Lifesciences (EW) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.","url":"https://finance.yahoo.com/news/edwards-lifesciences-ew-2-since-163107918.html"},{"category":"company","date":1709801580,"headline":"Micron upgraded, Foot Locker downgraded: Wall Street's top analyst calls","id":126379350,"image":"","symbol":"EW","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3386573661"},{"category":"company","date":1709799180,"headline":"What's Driving DexCom Inc's Surprising 13% Stock Rally?","id":126377077,"image":"","symbol":"EW","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3386517583"},{"category":"company","date":1709798820,"headline":"Edwards Lifesciences upgraded to Buy at BofA after 'bullish' management meetings","id":126386362,"image":"","symbol":"EW","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3386511516"},{"category":"company","date":1709791560,"headline":"What 9 Analyst Ratings Have To Say About Edwards Lifesciences","id":126386363,"image":"","symbol":"EW","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3386370524"},{"category":"company","date":1709787840,"headline":"BofA gets more bullish on Edwards Lifesciences, upgrades shares","id":126386364,"image":"","symbol":"EW","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3386312845"},{"category":"company","date":1709774220,"headline":"BofA upgrades Edwards to buy, says double-digit growth is back","id":126382887,"image":"","symbol":"EW","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3386964271"},{"category":"company","date":1709736180,"headline":"Edwards (EW) Gains From RESILIA's Global Adoption, TAVR Growth","id":126356060,"image":"","symbol":"EW","publisher":"Yahoo","summary":"With the Critical Care spin-off, Edwards (EW) is looking to pursue growth in TAVR, TMTT and Surgical, as well as new investments in interventional heart failure technologies.","url":"https://finance.yahoo.com/news/edwards-ew-gains-resilias-global-144300524.html"}]}